December 2012, Volume 34, No. 4
Original Articles

A pilot study on sexually transmitted diseases and high risk sexual behaviour in Hong Kong female ketamine users

Jacqueline HS Lee 李灝思, Rachel YK Cheung 張優嘉, Symphorosa SC Chan 陳丞智, Albe WL Pang 彭煒琳, Tony KH Chung 鍾國衡

HK Pract 2012;34:132-144

Summary

Objective: To explore sexual attitude, high risk sexual behaviour and prevalence of sexually transmitted diseases (STD) in Hong Kong female ketamine users.
Design: Cross-sectional study. Participants were recruited from a rehabilitation centre and seen in a gynaecological clinic. They completed a questionnaire, underwent a gynaecological and obstetrics history interview and had a STD screening.
Subjects: Thirty-six women with illicit ketamine use.
Main outcome measures : Sexual attitude and behaviour, prevalence of STD.

Results: Two thirds of participants had their first sexual intercourse at or below 16 years old. 25.1% had 10 or more sexual partners. 27.8%, 91.7% and 25% thought that one night stand, premarital sex and having more than one sexual partner at the same time, respectively, were acceptable. 25% and 41.6% had history of STD and termination of pregnancy respectively. 8.3% were screened positive for Chlamydia. Participants with ≤ 3 years of ketamine use were less likely to have more than one sexual partner at the same time (P < 0.05, OR = 0.136, 95% CI = 0.024 to 0.775) or history of STD (P < 0.05) when compared to those with >3 years of ketamine use. Longer ketamine use was related to more termination of pregnancies (P = 0.02). Those who started taking ketamine at younger age were more likely to start sexual intercourse at a younger age (P = 0.02).
Conclusion: Female ketamine users had a permissive sexual attitude and had high risk sexual behaviours.
This group was at high risk of STD and termination of pregnancy and should be targeted for intervention.

Keywords: Illicit drug use , ketamine , sexually transmitted diseases, sexual attitude, high risk sexual behaviour

摘要

目的:研究香港濫用氯胺酮少女的性觀念,高危性行為及感染性病之普遍性。

設計:橫切面式調查。由2009年11月至2010年2月,在威爾斯親王醫院婦科門診部招募來自某戒毒所的少女進行研究。她們填寫一份關於性觀念及高危性行為的問卷,並接受婦產科病史面談及性病篩選檢查。

研究對象:濫用氯胺酮的少女。

主要測量內容:性觀念,高危性行為及感染性病之普遍性。

結果:共36位濫用氯胺酮少女參與是項研究。其中三分二在16歲或以下己開始發生性行為。25.1%有10個或以上性伴侶;27.8%接受一夜情;91.7%接受婚前性行為;25%同時有多於一位性伴侶。25%曾患性病;41.6%曾經墮胎。8.3%之衣原體篩查結果呈陽性反應。相比起吸食氯胺酮達3年以上的少女, 吸食3年或以下的較少患性病或同時有多於一位性伴侶。濫用氯胺酮時間愈長者,會較多有墮胎經歷。年紀愈小開始吸食氯胺酮,也會較早開始發生性行為。

結論:濫用氯胺酮少女性觀念開放,及多有高危性行為。同時亦有高的感染性病率及墮胎率。此高危族群需受到關注,以免出現高危性行為的後遺症問題。

主要詞彙: 濫用藥物、氯胺酮、性病、性觀念、高危性行為


Introduction

There has been a progressive liberalization in attitudes towards sex in many Asian societies which had previously been comparatively conservative. The age of sexual debut has been decreasing worldwide.1 Similar trend is seen in Hong Kong. The number of 15-18 years old females having sexual experience has increased from 5.2% in 2001 to 8.2% in 2006.2,3 This increase in sexual activity has increased the vulnerability of young people to sexually transmitted diseases (STDs). The United Nations had estimated that about half of new HIV infections worldwide will occur among young people aged 15 to 24.4

STD has an adverse impact on the reproductive health of females. Chlamydia infection is associated with infertility and unintended pregnancies expose an individual to the risks associated with termination of pregnancies such as pelvic inflammatory diseases and cervical incompetence.5

Illicit drug use is on the rise in Hong Kong among youngsters under 21, numbering 3430 drug abusers in 2008 compared to 2999 in 2007.6 Illicit drug use had always been linked with high risk sexual behaviour.7,8 They were reported to have a greater number of sexual partners, more STDs and higher pregnancy rates compared to those without illicit drug use.7,8 Although there had been many studies investigating the sexual behaviour and prevalence of STD among undergraduates or college students, such information on illicit drug users is still scarce.Ketamine is an on competitive glutamate N-methyl-d-aspartate receptor antagonist with well documented safety in medical use. However, the recreational use of it in Hong Kong, especially among adolescents, has created new medical and social problems.9 It is the commonest psychotropic drug being abused in Hong Kong since 2001.6

We conducted this study to investigate the sexual attitude, high risk sexual behaviour and prevalence of STDs in Hong Kong female ketamine users. There is no prior local data in this area. This study can reveal the magnitude of high risk sexual behaviours and its associated consequences in female ketamine users, which numbers are on the rise in Hong Kong. This may facilitate the formulation of effective interventions to promote sexual health in this particularly high risk group.

Methods

The study was carried out in Prince of Wales Hospital in Hong Kong, from November 2009 to February 2010. All non-pregnant Chinese women who had a previous history of ketamine use were referred to our gynaecology clinic from a local drug rehabilitation centre. All of them who attended our clinic were invited and those who refused to join the study were excluded. A written explanation of the study was provided by a female research assistant and written informed consent was obtained. Participants filled in a 47 item questionnaire (Appendix 1) in a private room. The questions were designed so that they could reflect the participant’s sexual attitude and behaviour. Trained researchers provided explanations if required and reviewed the questionnaire for completeness. The questionnaire included 19 items on pattern of ketamine use and use of other illicit drugs. Sexual attitudes, sexual behaviour, contraception practice and history of STD were explored with 20 questions. Most questions were in a yes or no format and option of “no comment” was provided. Demographic data were also obtained. The participants would then be interviewed by a researcher and asked about gynaecological and obstetrics history, details of STD acquired and treatment received. All participants were interviewed by the same investigator who was blinded to the questionnaire results. Screening for STD include hepatitis B surface antigen (HbsAg), anti-hepatitis C virus antibodies (anti- HCV), HIV, Venereal Disease Research Laboratory test (VDRL) and high vaginal swab for bacterial culture, endocervical swabs for gonorrhoea and Chlamydia cultures. Chi square test was used to compare categorical variables. Fisher's exact test was used when there were more than 20% of cells with an expected value of less than 5 in a contingency table. Analysis of variance (ANOVA) was used to compare categorical variables with continuous variables. All analyses were performed with the Statistical Package for Social Science version 17.0 (SPSS Inc., IL, USA). The significance level was set as P < 0.05

Ethics Approval:

The study was approved by the local institutional ethics committee (CRE Ref: 2009.453).

Results

During the study period, 38 ketamine users were referred to our unit for assessment and 36 agreed to participate in the study. All of them filled in the questionnaire and were interviewed by the investigator. Thirty-five out of the 36 participants underwent STD screening. STD screening was not performed in one participant because she was not sexually active. The demographic data and pattern of ketamine use were shown in Table 1 and 2 respectively. The mean age was 19.8 (SD = 3.41) years (range 13 to 29 years old). Details of sexual behaviour and contraception were shown in Table 3 and Table 4 respectively.Nine (25%) reported a history of STD or pelvic inflammatory disease . Among them, three had Chlamydia, two had trichomonas, one had gonorrhoea, one had syphilis, one had genital warts and one had tubo-ovarian abscess (Table 5). All nine reported completion of treatment before the current consultation. However, STD screening performed at the time of study in all sexually active participants (n=35) detected Chlamydia infection in 8.3% and reactive VDRL in 2.8% (Table 5). Besides, 22.2%, 11.1% and 8.3% had one, two or three termination of pregnancies respectively (Table 5) and 2 (5.6%) had a previous confinement. Comparing the 2 groups (ketamine use ≤ 3 years and > 3 years) with Chi square test, less participants in the group with ketamine use of ≤ 3 years had more than 1 sexual partner at the same time (P < 0.05, OR 0.136, 95% CI = 0.024 to 0.775) or had history of STD (P < 0.05) (Table 6).A one way between groups analysis of variance test indicated a statistically significant difference in age of first sexual intercourse among the 6 age-groups of first ketamine use (P = 0.02). Post hoc comparison indicated that age-group 10 to 12 was significantly different from age-group older than 18 years old (P < 0.05, Table 7). Taking ketamine at a younger age was related to having first sex at a younger age.Similarly, there was also a statistically significant difference in number of termination of pregnancy between the 5 groups of duration of ketamine use(P = 0.02). Post hoc comparison indicated that the number of termination of pregnancy in the duration-group of more than 2 to 3 years of ketamine use was significantly different from the more than 6 years of ketamine use duration-group (P < 0.05, Table 7). Longer duration of ketamine use was related to more termination of pregnancies.There was no statistically significant difference between the frequency of contraceptive use with or without ketamine use (P = 0.70).The frequency of ketamine use was not found to be related to the number of termination of pregnancy (P = 0.89) or history of STD (P = 0.67).

Discussion

Our study included young female ketamine users with a mean age of 19.8 years (SD = 3.4) and an education of up to secondary level. They had a more permissive sexual attitude. Their acceptance towards premarital sex or having mor e than one s exua l partner were as high as 91.7% and 25% respectively, comparing with 44% and 7% among 14 to 17 years old reported in another local study.2 This permissive attitude explained their much higher prevalence of sexual activity (97.2%) as compared with 8.2% reported in another local study.3 The age of first sexual intercourse was significantly lower for those who started taking ketamine at 10 to 12 years of age (mean 13.4 years of age) compared to those who started taking ketamine at >18 years of age (mean 17.5 years). Ketamine user were also more likely to engage in high risk sexual activity with 36.1% having more than one sexual partner at the same time and 52.9% had more than five life time sexual partners, 8.4% even had more than ten life time sexual partners. These results show that ketamine users have much higher risky sexual behaviours and have more consequences of high risk sexual behaviours such as having STD which were shown in the other results of this study.Up to 25% of participants had a history of STD and 11.1% were found to be suffering from STD during our screening. This was much higher than 1.5% to 8.9% in other Asian countries.10,11 Less participants in the group of less than or equal to 3 years of ketamine use had history of STD when compared to the group with ketamine use for > 3 years (P = 0.05). Duration of ketamine use can be regarded as an indirect reflection of the duration of an individual’s overall high risk behaviour. Therefore longer duration of ketamine use is associated with longer exposure to high risk sexual behaviour and its consequences, e.g. STD. Ketamine users are a high risk group from a number of perspectives. Targeting them by offering STD screening or education on STD prevention when they present to medical personnel for other problems allows more effective use of limited resources. Selective screening of Chlamydia infection was shown to be effective in reducing incidence of pelvic inflammatory disease.12 Some had proposed to include STD screening and treatment in standard treatment programmes.13 These efforts, from an individual perspective, can promote reproductive health; while, in a global perspective, can reduce the burden of the ever increasing incidence of HIV. However, drug abuse is illegal and this group is difficult to identify. Medical personnel in a primary care setting are in a good position to provide such intervention since drug abuse is associated with various consequences necessitating medical attention. In our study, 41.7% of participants had consulted a doctor for side effects related to ketamine. Appropriate training for general practitioners is important in the delivery of STD
prevention information. From previous studies, 27.1% of general practitioners felt there was an inadequate access to counselling and education resources.14 The results of this study showed that female ketamine users had more high risk sexual behaviour, more liberal sexual attitude, more termination of pregnancy and more STD. Some of the figures were alarmingly high, e.g. 30.6% had first sexual intercourse at ≤ 13 years old. These exposed them to further risks of surgical complications and infertility. Interventions such as STD screening, provision of STD prevention information in a primary care setting may be effective in promoting sexual health in this group. These patients are difficult to identify and even more difficult to recruit for analysis. Our study, although small in number, is the first study to report sexual behaviour and STD in this group of subjects in our locality.

Limitations of study

Ketamine abuse is limited to a specific population in Hong Kong and it is difficult to find a large sample size of subjects who are willing to participate. To identify them more effectively, healthy promotion, education and collaborations with various organizations which help ketamine users can do. This is also a biased group as they are a hospital clinic-based population. This study is limited by selection bias as they were all female subjects referred from a rehabilitation centre. The conclusion cannot be generalized to the male subjects and it may not reflect the same conditions in all ketamine users in our community. This is a cross-sectional study and cannot address causal relationships between ketamine use and high risk sexual behaviour. Results of this study might also be affected y recall bias and under reporting. However, under reporting generally results in fewer positive findings. It is likely that the positive response will likely be even higher than the ones reported here.

Conclusion
Ketamine use is an increasing problem in Hong Kong. This group has liberal sexual attitudes and very high risk sexual behaviour. They are at a higher risk of contracting STDs and having termination of pregnancies. The longer the duration of ketamine use, the higher is this risk. This group therefore constitutes a particularly high risk group to be targeted for intervention.

Acknowledgement

This study was financially supported by the Beat Drug Fund 2010, Narcotics Division, Security Bureau,
Government of the Hong Kong Special Administrative Region.

OA1OA2
OA3OA4
OA5
OA6-7
OA key


Jacqueline HS Lee, MBChB (CUHK)
Resident

Rachel YK Cheung, MBChB (CUHK), MRCOG, FHKCOG, FHKAM (Obstetricians and Gynaecologists)
Associate Consultant

Symphorosa SC Chan, MBChB (CUHK), MRCOG, FHKCOG, FHKAM (Obstetricians and Gynaecologists)
Consultant

Albe WL Pang, Bachelor of Science (University of Queensland)
Research Assistant

Tony KH Chung, MBBS (University of Sydney), MD (CUHK), FRANZCOG, FHKCOG
Professor
Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong,
Prince of Wales Hospital, Shatin, NT, Hong Kong SAR.

Correspondence to: Dr Jacqueline HS Lee, Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong SAR.

Email: jaclee@cuhk.edu.hk 


Reference
  1. Wellings K, Nanchahal K, Macdowall W, et al. Sexual behaviour in Britain: early heterosexual experience. Lancet 2001;358:1843-1850.
  2. Youth Sexuality Study 2001. Family Planning Association of Hong Kong.
    http://www.famplan.org.hk/fpahk/common/pdf/ar-01-02/Youth%20Sexuality %20Study%2001.pdf. Assessed 9th March, 2011.
  3. Youth Sexuality Study 2006. Family Planning Association of Hong Kong.
    http://www.famplan.org.hk/fpahk/en/press/press/071123-press-eng.pdf.
    Assessed 9th March, 2011.
  4. UNAID/WHO: AIDS Epidemic Update: December 2006.
    http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf. Assessed 9th March, 2011.
  5. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first trimester
    abortion: a report of 170,000 cases. Obstet Gynecol 1990;76:129-135.
  6. Drug Abuse Trends for 1999 – 2008. Central Registry of Drug Abuse Fiftyeighth
    Report Chapter 2. The Central Registry of Drug Abuse.
    http://www.nd.gov.hk/pdf/fifth_three_year_plan_ch2_e.pdf. Assessed 9th March, 2011.
  7. Brook JS, Adams RE, Balka EB, et al. Illicit drug use and risky sexual
    behavior among African American and Puerto Rican urban adolescents: the longitudinal links. J Genet Psychol 2004;165:203-220.
  8. Vivancos R, Abubakar I, Hunter PR. Sex, drugs and sexually transmitted infections in British university students. Int J STD AIDS 2008;19:370-377.
  9. Chu PS, Kwok SC, Lam KM, et al. Street ketamine associated bladder dysfunction. Hong Kong Med J 2007;13:311-313.
  10. Ma Q, Ono-Kihara M, Cong L, et al. Sexual behavior and awareness of Chinese university students in transition with implied risk of STIs and HIV infection: a cross-sectional study. BMC Public Health 2006;18:232.
  11. Lee SJ, Cho YH, Ha US, et al. Sexual behavior survey and screening for chlamydia and gonorrhoea in university students in South Korea. Int J Urol 2005;12:187-193.
  12. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362–1366.
  13. Ross MW, Hwang LY, Zack C, et al. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int J STD AIDS 2002;13:769-774.
  14. Khan A, Plummer D, Hussain R, et al. Preventing sexually transmissible infections in Australian general practice. Int J STD AIDS 2008;19:459-463.